BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17451426)

  • 1. Beta cells in type 2 diabetes - a crucial contribution to pathogenesis.
    Maedler K
    Diabetes Obes Metab; 2008 May; 10(5):408-20. PubMed ID: 17451426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
    Karaca M; Magnan C; Kargar C
    Diabetes Metab; 2009 Apr; 35(2):77-84. PubMed ID: 19251449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
    Donath MY; Böni-Schnetzler M; Ellingsgaard H; Ehses JA
    Physiology (Bethesda); 2009 Dec; 24():325-31. PubMed ID: 19996363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical versus functional beta-cell mass in experimental diabetes.
    Kargar C; Ktorza A
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():43-53. PubMed ID: 18834432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of beta-cell management in type 2 diabetes.
    Standl E
    Int J Clin Pract Suppl; 2007 Jun; (153):10-9. PubMed ID: 17594389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.
    Topp BG; Atkinson LL; Finegood DT
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1730-5. PubMed ID: 17895283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Gastaldelli A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S60-5. PubMed ID: 21864753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus.
    Kruit JK; Brunham LR; Verchere CB; Hayden MR
    Curr Opin Lipidol; 2010 Jun; 21(3):178-85. PubMed ID: 20463468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.
    Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in the pathophysiology of diabetes mellitus.
    Lee SC; Pervaiz S
    Int J Biochem Cell Biol; 2007; 39(3):497-504. PubMed ID: 17074529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models.
    Liadis N; Salmena L; Kwan E; Tajmir P; Schroer SA; Radziszewska A; Li X; Sheu L; Eweida M; Xu S; Gaisano HY; Hakem R; Woo M
    Diabetes; 2007 Sep; 56(9):2302-11. PubMed ID: 17563067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones and the preservation of beta-cell function, cellular proliferation and apoptosis.
    Decker M; Hofflich H; Elias AN
    Diabetes Obes Metab; 2008 Aug; 10(8):617-25. PubMed ID: 17645549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth.
    Holloway AC; Petrik JJ; Bruin JE; Gerstein HC
    Diabetes Obes Metab; 2008 Sep; 10(9):763-71. PubMed ID: 17970760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic beta-cell hyperactivity in morbidly obese adolescents.
    Mercado AB; Castells S
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():560-3. PubMed ID: 17237743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma proteome changes in subjects with Type 2 diabetes mellitus with a low or high early insulin response.
    Sundsten T; Zethelius B; Berne C; Bergsten P
    Clin Sci (Lond); 2008 Apr; 114(7):499-507. PubMed ID: 17961122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.